Drug Pipeline

Litifilimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
5
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
4
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04961567 A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… Lupus Erythematosus, Systemic Active, Not Recruiting
NCT04895241 A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… Lupus Erythematosus, Systemic Active, Not Recruiting
NCT06044337 A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059)… Subacute Cutaneous Lupus Erythematosus Enrolling by Invitation
NCT05352919 An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… Systemic Lupus Erythematosus (SLE) Enrolling by Invitation
Phase 2/3
NCT05531565 A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… Subacute Cutaneous Lupus Erythematosus Recruiting
Sponsors Running Litifilimab Trials
Disease Areas
Get alerts when Litifilimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free